本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ABVC BioPharma, Inc.

3.37
-0.1500-4.26%
成交量:30.34万
成交额:103.25万
市值:5,476.57万
市盈率:-15.03
高:3.58
开:3.52
低:3.30
收:3.52
数据加载中...
2024/03/26

重要事件披露

Form 8-K - Current report
2024/03/22

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/15

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/03/14

重要事件披露

Form 8-K - Current report
2024/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/29

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/17

SEC问询函

Form CORRESP - Correspondence
2024/02/16

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/10

SEC问询函

Form CORRESP - Correspondence
2024/02/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/08

重要事件披露

Form 8-K - Current report
2024/01/26

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/01/17

重要事件披露

Form 8-K - Current report
2024/01/17

重要事件披露

Form 8-K - Current report
2024/01/17

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/01/12

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/11/20

重要事件披露

Form 8-K - Current report